120 related articles for article (PubMed ID: 31814456)
1. Pyrrole derivatives as potential anti-cancer therapeutics: synthesis, mechanisms of action, safety.
Kuznietsova H; Dziubenko N; Byelinska I; Hurmach V; Bychko A; Lynchak O; Milokhov D; Khilya O; Rybalchenko V
J Drug Target; 2020 Jun; 28(5):547-563. PubMed ID: 31814456
[TBL] [Abstract][Full Text] [Related]
2. [Effect of dihydropyrrol and maleimide derivatives on the state of the liver and colon in normal rats and those with colorectal carcinogenesis induced by dimethylhydrazine].
Kuznietsova HM; Lynchak OV; Danylov MO; Kotliar IP; Rybal'chenko VK
Ukr Biokhim Zh (1999); 2013; 85(3):74-84. PubMed ID: 23937051
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of 4-amino-3-chloro-1
Kuznietsova HM; Hurmach VV; Bychko AV; Tykhoniuk OI; Milokhov DS; Khilya OV; Volovenko YM; Rybalchenko VK
In Silico Pharmacol; 2019; 7(1):2. PubMed ID: 31032168
[TBL] [Abstract][Full Text] [Related]
4. Impact of dihydropyrrol derivative on the normal colonic mucosa of DMH-induced colon cancer rats compared with 5-fluorouracil.
Kuznietsova HM; Ogloblya OV; Rybalchenko VK
Exp Oncol; 2013 Mar; 35(1):25-9. PubMed ID: 23528312
[TBL] [Abstract][Full Text] [Related]
5. Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors.
Barbosa ML; Lima LM; Tesch R; Sant'Anna CM; Totzke F; Kubbutat MH; Schächtele C; Laufer SA; Barreiro EJ
Eur J Med Chem; 2014 Jan; 71():1-14. PubMed ID: 24269511
[TBL] [Abstract][Full Text] [Related]
6. [MORPHOFUNCTIONAL STATE OF BLOOD CELLS AFTER CHRONIC EXPOSURE OF THE PROTEIN KINASES INHIBITOR MALEIMIDE DERIVATIVE].
Byelinska IV; Lynchak OV; Tsyvinska SM; Rybalchenko VK
Fiziol Zh (1994); 2015; 61(4):71-7. PubMed ID: 26552308
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5-Amyno-4-(1,3-benzothyazol-2-yn)-1-(3-methoxyphenyl)-1,2-dihydro-3H-pyrrol-3-one Intake on Digestive System in a Rat Model of Colon Cancer.
Kuznietsova HM; Luzhenetska VK; Kotlyar IP; Rybalchenko VK
ScientificWorldJournal; 2015; 2015():376576. PubMed ID: 26504896
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of novel 3-aryl-4-(1H-indole-3yl)-1,5-dihydro-2H-pyrrole-2-ones as vascular endothelial growth factor receptor (VEGF-R) inhibitors.
Peifer C; Selig R; Kinkel K; Ott D; Totzke F; Schächtele C; Heidenreich R; Röcken M; Schollmeyer D; Laufer S
J Med Chem; 2008 Jul; 51(13):3814-24. PubMed ID: 18529047
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anti-tumour activity of new pyrimidine-pyrrole appended triazoles.
Thiriveedhi A; Nadh RV; Srinivasu N; Bobde Y; Ghosh B; Sekhar KVGC
Toxicol In Vitro; 2019 Oct; 60():87-96. PubMed ID: 31100376
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 3-substituted-4-(4-methylthio phenyl)-1H-pyrrole derivatives as potential anticancer agents.
Lan L; Qin W; Zhan X; Liu Z; Mao Z
Anticancer Agents Med Chem; 2014; 14(7):994-1002. PubMed ID: 24372525
[TBL] [Abstract][Full Text] [Related]
11. 3'-(4-(Benzyloxy)phenyl)-1'-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies.
Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Pottoo FH; Jha M
Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900262. PubMed ID: 32003485
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Evaluation of Cytotoxic Activity of Some Pyrroles and Fused Pyrroles.
Fatahala SS; Mohamed MS; Youns M; Abd-El Hameed RH
Anticancer Agents Med Chem; 2017; 17(7):1014-1025. PubMed ID: 28042776
[TBL] [Abstract][Full Text] [Related]
13. EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives.
Mourad AAE; Farouk NA; El-Sayed EH; Mahdy ARE
Life Sci; 2021 Jul; 277():119531. PubMed ID: 33887348
[TBL] [Abstract][Full Text] [Related]
14. Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile.
Mghwary AE; Gedawy EM; Kamal AM; Abuel-Maaty SM
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):838-852. PubMed ID: 30919701
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Anti-cancer Activity of 3-substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives.
Zhan X; Qin W; Wang S; Zhao K; Xin Y; Wang Y; Qi Q; Mao Z
Anticancer Agents Med Chem; 2017; 17(6):821-831. PubMed ID: 27671311
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinases as targets in cancer therapy - successes and failures.
Traxler P
Expert Opin Ther Targets; 2003 Apr; 7(2):215-34. PubMed ID: 12667099
[TBL] [Abstract][Full Text] [Related]
17. A promising anti-cancer and anti-oxidant agents based on the pyrrole and fused pyrrole: synthesis, docking studies and biological evaluation.
Fatahala SS; Shalaby EA; Kassab SE; Mohamed MS
Anticancer Agents Med Chem; 2015; 15(4):517-26. PubMed ID: 25929576
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Characterization of 4-Anilino-6,7-Dimethoxy Quinazoline Derivatives as Potential Anti-Angiogenic Agents.
Devegowda PS; Balaji KS; Prasanna DS; Swaroop TR; Kameshwar VH; Jayarama S; Siddalingaiah L; Rangappa KS
Anticancer Agents Med Chem; 2018 Feb; 17(14):1931-1941. PubMed ID: 28403784
[TBL] [Abstract][Full Text] [Related]
19. Suppression of systemic inflammation and signs of acute and chronic cholangitis by multi-kinase inhibitor 1-(4-Cl-benzyl)-3-chloro-4-(CF3-phenylamino)-1H-pyrrole-2,5-dione.
Kuznietsova H; Byelinska I; Dziubenko N; Lynchak O; Milokhov D; Khilya O; Finiuk N; Klyuchivska O; Stoika R; Rybalchenko V
Mol Cell Biochem; 2021 Aug; 476(8):3021-3035. PubMed ID: 33792809
[TBL] [Abstract][Full Text] [Related]
20. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
